Drugmaker Cheplapharm Said to Weigh IPO at $10 Billion Value (2)

Cheplapharm Arzneimittel GmbH, the German drugmaker, is weighing plans for an initial public offering in what could be one of Europe’s largest share sales of 2021, people familiar with the matter said.

Greifswald-based Cheplapharm is speaking with advisers about a potential listing as soon as this year, the people said, asking not to be identified discussing confidential information. A share sale could value the business at about 7 billion euros to 8 billion euros ($9.5 billion) or more, the people said.

Cheplapharm’s 500 million-euro secured notes due in February 2027 rallied 1.3 cents on the euro Friday to about ...